课题基金 / 基金详情

项目摘要

项目成果

PAUL M ALLEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The recognition of antigen by T cells is a seminal event in the induction of a specific immune response. The TCR recognizes a peptide bound to an MHC molecule (p/MHC) on the surface of an antigen presenting cell.! The TCR is a highly intricate receptor, but has a low affinity for the p/MHC ligand. The basis for thei exquisite TCR specificity, despite the low affinity, is still not known. A major advance in our understanding of how T cells recognize antigen has been the direct demonstration of the formation of an immunological synapse. The immunological synapse is a supramolecular structure at the interface between the T cell and a | single APC that is stable for many hours. The immunologicalsynapse provides the molecular machinery fori integration of p/MHC quality and quantity. These studies have provided a model explaining how a TCR can distinguish between closely related ligands, but many questions remain. In this proposal, our overall goal is to understand how mature T cells and thymocytes can respond to small kinetic and structural changes in the p/MHC ligands. Our laboratory has developed and utilized the Hb/I-Ek antigen system. We have generated and characterized a wide range of T cells, ligands, and transgenic mice for two T cells, 3.L2 and 2.102.i Through an integrated investigation of the 3.L2and 2.102 T cells and ligands we propose to explore several key issues including: 1) how do the TCR binding properties to a continuum of different strength ligands relate to their structure and biological effects, 2) how does the recognition by a single TCR of syngeneic and' allogeneic ligands compare, 3) how do immunological synapses in thymocytes compare to those of mature T cells, and 4) what is the role of CD4 in immunological synapse formation and TCR:p/MHC interactions? These proposed studies will provide key molecular details of the interaction between a TCR and the p/MHC ligand. These studies could lead to the development of novel pharmaceuticals which could control unwanted immune responses, such as an autoimmune response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CONTROL OF PERIPHERAL T CELL FUNCTION BY SELF-PEPTIDE/MHC
  • 批准号:
    9284381
  • 项目类别:
  • 资助金额:
    $22.88万
  • 财政年份:
    2016
  • 负责人:
    PAUL M ALLEN
  • 依托单位:
DEFINING HOST-MICROBIAL INTERACTIONS THAT TRIGGER INFLAMMATORY BOWEL DISEASE
  • 批准号:
    8579066
  • 项目类别:
  • 资助金额:
    $40.03万
  • 财政年份:
    2013
  • 负责人:
    PAUL M ALLEN
  • 依托单位:
DEFINING HOST-MICROBIAL INTERACTIONS THAT TRIGGER INFLAMMATORY BOWEL DISEASE
  • 批准号:
    8874214
  • 项目类别:
  • 资助金额:
    $50.66万
  • 财政年份:
    2013
  • 负责人:
    PAUL M ALLEN
  • 依托单位:
DEFINING HOST-MICROBIAL INTERACTIONS THAT TRIGGER INFLAMMATORY BOWEL DISEASE
  • 批准号:
    8688237
  • 项目类别:
  • 资助金额:
    $38.69万
  • 财政年份:
    2013
  • 负责人:
    PAUL M ALLEN
  • 依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    乔安娜
  • 依托单位: